Status:
UNKNOWN
Acute Physiological Responses to Twice Daily Blood Flow Restriction Training
Lead Sponsor:
Defence Medical Rehabilitation Centre, UK
Collaborating Sponsors:
University of Bath
Conditions:
Muscle Weakness
Muscle Damage
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The Academic Department of Military Rehabilitation (ADMR) is currently conducting a pan-defence, randomised control trial (RCT) investigating the utility of twice daily blood flow restriction training...
Eligibility Criteria
Inclusion Criteria:
- Age 18 - 55 years
- Must not have performed regular lower-limb resistance training for the last 6 months (participants must have performed < 1 lower-limb resistance training session per week over the previous 6 months)
- DMRC Staff member (civilian or service personnel)
Exclusion Criteria:
-
Any medical contraindication related to BFR*.
-
Any current lower-limb musculoskeletal injury
-
Restricted range of movement. i.e. Chronically locked knee or fixed flexion deformity.
-
Any physical impairment or co-morbidities (including cardio-vascular disease) precluding the safe participation in the intervention and/or assessment procedures
-
Non-musculoskeletal or serious pathological condition (i.e. Inflammatory arthropathy, infection or tumour).
-
Use of any medication which may contraindicate the performance of BFR or influence blood biomarkers of EIMD or inflammation.
-
Use of any performance enhancing supplements or ergogenic aids such as creatine monohydrate.
-
Any individual who is known to be currently pregnant
*Medical-based Exclusion Criteria (based on clinical contraindications to performing BFR):
-
History of cardiovascular disease (hypertension, peripheral vascular disease, thrombosis/embolism, ischaemic heart disease, myocardial infarction).
-
History of the following musculoskeletal disorders: rheumatoid arthritis, avascular necrosis or osteonecrosis, severe osteoarthritis.
-
History of the following neurological disorders: Peripheral neuropathy, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, severe traumatic brain injury.
-
Varicose veins in the lower-limb.
-
Acute viral or bacterial upper or lower respiratory infection at screening.
-
Known or suspected lower limb chronic exertional compartment syndrome (tourniquet raises intra-compartmental muscle pressure).
-
Postsurgical swelling.
-
Surgical insertion of metal components at the position of cuff inflation.
-
History of any of the following conditions or disorders not previously listed: diabetes, active cancer.
-
History of elevated risk of unexplained fainting or dizzy spells during physical activity/exercise that causes loss of balance
-
Increased risk of haemorrhagic stroke, exercise induced rhabdomyolysis.
Key Trial Info
Start Date :
November 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT06334224
Start Date
November 6 2023
End Date
September 1 2024
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Defence Medical Rehabilitation Centre
Loughborough, United Kingdom, LE12 5QW